Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

SHA:603998 Revenue

Hunan Fangsheng Pharmaceutical had revenue of 462.77M CNY in the quarter ending March 31, 2026, with 10.69% growth. This brings the company's revenue in the last twelve months to 1.79B, up 1.93% year-over-year. In the year 2025, Hunan Fangsheng Pharmaceutical had annual revenue of 1.75B, down -1.75%.

• Revenue (ttm): 1.79B
• Revenue Growth: +1.93%
• P/S Ratio: 2.58
• Revenue / Employee: 958.85K
• Employees: 1,807
• Market Cap: 4.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.75B	-31.05M	-1.75%
Dec 31, 2024	1.78B	148.95M	9.15%
Dec 31, 2023	1.63B	-163.46M	-9.12%
Dec 31, 2022	1.79B	225.03M	14.36%
Dec 31, 2021	1.57B	288.21M	22.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error